Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
shakedown.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
A community for live music fans with roots in the jam scene. Shakedown Social is run by a team of volunteers (led by @clifff and @sethadam1) and funded by donations.

Administered by:

Server stats:

242
active users

shakedown.social: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#cancertreatment

1 post1 participant1 post today
Public
Xamanismo Coletivo

"While #research restrictions on #ScheduleI substances severely hamper clinical research on #cannabis in humans, there is a large body of observational studies on #medicalcannabis and #cancer – as well as lab research – that looks at cannabis’s effect on tumors in test tubes and in animals. The analysis included as many of those studies as possible.

Analysis aims to solidify #agreement on cannabis’s potential as a #cancertreatment."

theguardian.com/us-news/2025/a

The Guardian · Medical cannabis shows potential to fight cancer, largest-ever study findsBy Hannah Harris Green
Public
Hari Tulsidas

Recent research emphasizes the significant impact of aligning cancer immunotherapy with the circadian clock. This approach optimizes treatment effectiveness and reduces side effects by synchronizing therapies with the body’s natural rhythms. Integrating circadian biology into cancer treatment represents a significant leap forward in personalized and patient-centered healthcare.

#CancerTreatment #Immunotherapy #CircadianRhythms #PersonalizedMedicine

sciencedaily.com/releases/2024.

Public
Matthew Merkovich

#CancerTreatment #CancerTreatmentRecovery

I Just wanted to give a gigantic thank you to all who gave me your emotional support here in the Fediverse while I was going through treatment (which was brutal). And now that I've had a couple of months of recovery (also brutal, often more so), and with an "all clear" PET scan, I just wanted to let you all know that I deeply and truly appreciate you.

Now can we finally get Universal Healthcare going in the U.S.?

Public
MarkG

Here's some important information about prescreening of cancer drugs. The guidelines for prescreening are based on studies that largely leave out populations that aren't white. See article for more detail:

cbc.ca/news/canada/toronto/can

CBCThis commonly prescribed cancer drug was supposed to help save his life, instead it killed him | CBC NewsAfter being diagnosed with colon cancer earlier this year, Dr. Anil Kapoor of Ontario was prescribed the common chemotherapy medication Fluorouracil. Three weeks later, he died from a toxic reaction to it. His brothers are on a mission to uncover who is most at risk and what the Canadian health-care system should do about it.
#CancerTreatment#Health
Public
Hari Tulsidas

A groundbreaking discovery has been made in the field of cancer research. Scientists have found a way to revert cancer cells back into normal cells. This could have major implications for the treatment of cancer, potentially leading to new therapies that target the root cause of the disease. #cancerresearch #cancerdiscovery #cancertreatment thebrighterside.news/post/majo

Public
MountainWitch ⛤:flag_bisexual:

This is amazing. My son had complete remission from AML 22 years ago with a bone marrow transplant (from his sister). It was a long horrendous period of healing for him. If this new drug can heal people into the future, it would be an incredible advancement in treatment for leukemia.

english.elpais.com/science-tec

EL PAÍS EnglishAn experimental pill achieves complete cancer remission in 18 people with aggressive leukemiaPreliminary results for the pharmaceutical revumenib suggest that it may have saved lives of terminal patients, including the young architect Algimante Daugelaite
#medicine#cancertreatment#MedicalScience
Public
Coach Pāṇini ®

“Personalized cancer vaccines are designed to prime the immune system so that a patient can generate a tailored antitumor response specific to their tumor mutation signature.” investors.modernatx.com/news/n

investors.modernatx.comModerna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA(R) (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 TrialmRNA-4157/V940, in combination with KEYTRUDA, demonstrated a statistically significant and clinically meaningful reduction in the risk of disease recurrence or death compared to KEYTRUDA monotherapy in stage III/IV melanoma patients with high risk of recurrence following complete resection Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial Companies plan to discuss results with regulatory authorities and initiate a Phase 3 study in melanoma in 2023 and rapidly expand to additional tumor types CAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / December 13, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial of mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with KEYTRUDA ® ,
#pharmaceuticals#cancertreatment#antitumor
ExploreLive feeds
About